$91.50 0.5%
EW Stock Price vs. AI Score (Last 150 days)
Data gathered: June 26

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Edwards Lifesciences

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.


Edwards Lifesciences
Price $91.50
Target Price Sign up
Volume 1,160,000
Market Cap $54.3B
Year Range $61.71 - $95.56
Dividend Yield 0%
PE Ratio 38.87
Revenue per Employee $355,156
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '241.61B875M1.21B352M526M0.660
Q4 '231.49B842M1.18B370M368M0.640
Q3 '231.5B790M1.13B385M423M0.590
Q2 '231.54B812M1.19B307M569M0.660
Q1 '231.47B766M1.13B341M477M0.620

Insider Transactions View All

Ullem Scott B. filed to sell 35,786 shares at $88.1.
June 20 '24
Lippis Daniel J. filed to sell 23,513 shares at $90.
June 20 '24
Ullem Scott B. filed to sell 30,561 shares at $87.5.
June 20 '24
BOBO DONALD E JR filed to sell 46,936 shares at $87.5.
June 12 '24
Zovighian Bernard J filed to sell 68,218 shares at $87.7.
May 30 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
Mar 6, 24 Buy $1K - $15K
Joshua Gottheimer
Democrat
Jan 7, 24 Buy $1K - $15K
John Curtis
Republican
Dec 15, 23 Sell $1K - $15K

What is the Market Cap of Edwards Lifesciences?

The Market Cap of Edwards Lifesciences is $54.3B.

What is Edwards Lifesciences' PE Ratio?

As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 38.87.

How Many People Work at Edwards Lifesciences?

As of our latest update, Edwards Lifesciences employed approximately 17,300 people worldwide. However, it's important to note that Edwards Lifesciences' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Edwards Lifesciences' revenue per employee?

$355,156. To calculate Edwards Lifesciences' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Edwards Lifesciences?

Currently, the price of one share of Edwards Lifesciences stock is $91.50.

How can I analyze the EW stock price chart for investment decisions?

The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.

Does EW offer dividends to its shareholders?

As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Edwards Lifesciences?

Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.